Photo: Reuters
The encouraging results of the tests of a vaccine against Ebola
tests, which began on September 2, was performed on 20 healthy volunteers in the US. They showed that the drug stimulates the immune system (immune) and promotes the body’s production of antibodies to fight the virus.
Scientists made a reservation, however, that the tests are still ongoing and it is too early to prejudge the final outcome of their.
– The safety profile is encouraging, as is the finding that a higher dose of the vaccine triggers the immune system reaction similar to that completely protected the animals against experimental Ebola – Dr. Anthony Fauci said the US National Institutes of Health (NIH). Also, other researchers have identified the results as “promising.”
As reported by Reuters, intramuscular vaccine was developed and produced in laboratories belonging to the British company GlaxoSmithKline pharmacological Okairos biotechnology company and the US National Institute on. Allergy and Infectious Diseases (NIAID). It contains genetic material from Zaire, a country in Central Africa, in which the current epidemic began and Sudan.
Volunteers, which tried the efficacy of the vaccine, there have been infected with the virus for ethical reasons. Studied only the effect of the preparation for the production of antibodies to combat Ebola and the immune system.
volunteer subjects ranged in age from 18 to 50 years. They were divided into two groups, the first of which received the lower and the second higher dose. In all the detected antibodies to fight Ebola, while those who received higher doses were detected more.
According to the latest, published on Wednesday, the World Health Organization (WHO), so far died of Ebola 5,689 people and infected 15,935. The epidemic took three West African countries – Guinea, Sierra Leone and Liberia.
(RZ)
The encouraging results of the tests of a vaccine against Ebola – Onet.pl
No comments:
Post a Comment